These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens. Greiner J; Döhner H; Schmitt M Haematologica; 2006 Dec; 91(12):1653-61. PubMed ID: 17145602 [TBL] [Abstract][Full Text] [Related]
4. Current status of vaccination therapy for leukemias. Reichardt VL; Brossart P Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663 [TBL] [Abstract][Full Text] [Related]
5. Peptide vaccines for patients with acute myeloid leukemia. Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762 [TBL] [Abstract][Full Text] [Related]
6. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy. Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232 [TBL] [Abstract][Full Text] [Related]
7. [Experimental study on immunotherapy with dendritic cell in leukemic mice model]. Li XX; Chen XL; Ma DX; Liu CS; He XP Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):73-7. PubMed ID: 16732955 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cell vaccines in acute leukaemia. Duncan C; Roddie H Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts. Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634 [TBL] [Abstract][Full Text] [Related]
10. Vaccine- and immune-based therapy in chronic lymphocytic leukemia. Le Dieu R; Gribben J Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069 [TBL] [Abstract][Full Text] [Related]
11. Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response. Hus I; Schmitt M; Tabarkiewicz J; Radej S; Wojas K; Bojarska-Junak A; Schmitt A; Giannopoulos K; Dmoszyńska A; Roliński J Leukemia; 2008 May; 22(5):1007-17. PubMed ID: 18323802 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962 [TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches]. Mohty M; Gaugler B; Calmels B; Blaise D; Vey N; Chabannon C; Olive D Bull Cancer; 2003; 90(8-9):751-7. PubMed ID: 14609765 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications. van de Loosdrecht AA; van den Ancker W; Houtenbos I; Ossenkoppele GJ; Westers TM Handb Exp Pharmacol; 2009; (188):319-48. PubMed ID: 19031033 [TBL] [Abstract][Full Text] [Related]
15. Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia. Klammer M; Roddie PH Expert Rev Vaccines; 2006 Apr; 5(2):211-22. PubMed ID: 16608421 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells. Troeger A; Meisel R; Moritz T; Dilloo D Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533 [TBL] [Abstract][Full Text] [Related]
17. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients. Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017 [TBL] [Abstract][Full Text] [Related]
18. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia. Klammer M; Waterfall M; Samuel K; Turner ML; Roddie PH Br J Haematol; 2005 May; 129(3):340-9. PubMed ID: 15842657 [TBL] [Abstract][Full Text] [Related]
19. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting. Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077 [TBL] [Abstract][Full Text] [Related]
20. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells. Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]